Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-21-011516

Sr. VP, New Product Dev. acquired 6,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kieffer Tara Lynn · Sr. VP, New Product Dev.

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-19 Grant or award : show line 1 in the form +6,800 6,800 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-19 Grant or award : show line 2 in the form Stock Option (right to buy) +28,400 28,400 D
Loading xslF345X03/form4.xml…